MedPath

Antiox

Brand Name: Antiox

Generic Name: Mebendazole

Active
Registration Number

DR-XY40801

Dosage Form

Chewable tablet

Issuance Date

April 19, 2022

Expiry Date

April 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg
PackagingClear PVC-Alu blister pack x 4's/Box of 36's

Classification

C
Classification
Over-The-Counter (OTC)
P
Pharmacologic
Anthelmintics (Benzimidazole derivatives)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

MebendazoleActive
Monograph: Mebendazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.